TP53BP1 and glioma: To validate this further, we compared the effect of GSK3Bi on sensitization of SB28 mouse glioma tumor cells with 53BP1-null versus T334A to PARPi-induced cytotoxicity in in vitro cell survival and in in vivo C57BL6 mouse subcutaneous tumor control.